To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

General Financial Topics

Andrew Smith
Within a complex and expensive health system, there are ways to cut both individual and societal costs without harming the quality of care.
Tamera Anderson-Hanna
There is no doubt that cancer can be costly, but there are some things you can do to help lessen the financial impact of the disease.
Brielle Urciuoli
Researchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced bladder cancer. Drug costs were compared between the US, UK, Canada and Australia.
Brielle Urciuoli
Until recently, Herceptin, which is used to treat patients with metastatic breast cancer, was fully covered under Humana’s South Florida Medicare Advantage plans. But, after taking it off the preferred drug list, patients will now be responsible for 20 percent of the drug’s cost, better aligning South Florida’s plans with Humana’s other Medicare Advantage plans.
Victoria Puzo, LCSW
For many cancer survivors, returning to work can be both exciting and anxiety-inducing. Knowing your rights and making a plan can help ensure a smooth transition.
Kim Johnson
No matter how expensive treatment was, we didn’t want to put a price tag on my sister’s life.
Martha Carlson
A major insurer takes a 20-year, first-line standard treatment off its preferred list in one market. But where will it end?
Brielle Urciuoli
NextSource Pharma, a small pharmaceutical company based in Florida, acquired the drug lomustine from Bristol-Myers Squibb, changed its brand name to Gleostine, and changed the price – by about 1,400 percent.
Bonnie Annis
Most Americans have insurance. We find comfort in knowing our future is secure in the event of a health crisis. But how do we know how much insurance is enough? Is it wise to take our specialized policies?
Katie Kosko
Musella’s plan for the Brain Tumor Virtual Trial Registry is to get patients access to more drugs at a faster pace, while collecting treatment and efficacy information that can later be used by oncologists across the country to treat others.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable